A medical evacuation technology, championed by the late Microsoft co-founder Paul Allen after the 2014 Ebola outbreak, proved vital during the early stages of the COVID-19 pandemic. This system played a significant role in safely transporting Americans who had contracted the virus from a quarantined cruise ship in Japan.
In the wake of the Ebola crisis in West Africa, Allen provided $5 million to help develop advanced capabilities for biocontainment, ensuring safe transportation for patients suffering from highly contagious diseases. This initiative resulted in the creation of specialized isolation systems designed to safeguard both patients and medical staff during transport.
### From Ebola to COVID-19
The technology, known as the Containerized Biocontainment System (CBCS), was developed by MRIGlobal, a biocontainment and global health engineering firm based in Kansas City. It was established through a public-private partnership including the US Department of State and the Paul G. Allen Foundation, in response to the urgent need for safe patient transport during the Ebola outbreak. The system allowed for the secure transfer of infected individuals over long distances without endangering medical staff, flight crews, or the public.
Years later, the same technology was utilized in the initial evacuations amid the COVID-19 pandemic. On February 17, 2020, approximately 14 US citizens who tested positive for the coronavirus were evacuated from the Diamond Princess cruise ship, which had been under quarantine for over ten days off the coast of Japan. Instead of being stranded, these patients were transported in specialized containment units on a chartered flight equipped with standard biosafety protocols, ensuring their safety as they were taken to treatment facilities in the United States.
### How the System Works
MRIGlobal designed the CBCS as a reusable, flight-ready unit that can easily be loaded onto government or civilian cargo aircraft. These sturdy units are built to securely contain highly contagious pathogens, facilitating the safe transport of critically ill patients while maintaining strict biocontainment standards. Dean Gray, a director at MRIGlobal, expressed pride in their role in safeguarding lives during medical emergencies. He emphasized that there is no equivalent to the CBCS for medical transport by air, pointing out that it was specifically developed to address urgent global health challenges like the COVID-19 outbreak, with the vital objective of saving lives.
By February 2020, MRIGlobal had designed and delivered four CBCS units, all actively used by the US government. The significance of this system was recognized even before the pandemic, as it received the R&D 100 Award for Innovation from R&D Magazine in 2016, an honor given annually to the most significant technological innovations of that year.
### A Lasting Legacy
While Paul Allen is primarily known for co-founding Microsoft with Bill Gates, his contributions extended far beyond technology. His investments in scientific research, public health, and disaster response demonstrate his commitment to improving global health. The successful use of the biocontainment transport system during the COVID-19 pandemic illustrates how foresight and funding made in response to the Ebola crisis were crucial in addressing another major global health challenge.
